← Open Payments lookup

MADONNA UGBOR: Open Payments

NPI 1124423256 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,183 in 106 payments from 11 companies in 2025. Trend: 2023 $1,781 · 2024 $1,864 · 2025 $3,183

Food & beverage: $3,172Education: $12
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$571
Alkermes, Inc.16$465
Lundbeck LLC22$447
E.R. Squibb & Sons, L.L.C.8$342
Vanda Pharmaceuticals Inc.10$316
Janssen Pharmaceuticals, Inc6$304
Neurocrine BioSciences, Inc.7$259
Otsuka America Pharmaceutical, Inc.6$217
Teva Pharmaceuticals USA, Inc.9$203
ABBVIE INC.2$43

Products named: CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, COBENFY, INVEGA SUSTENNA, INGREZZA, FANAPT, HETLIOZ.

Industry payments across MD — which companies pay providers there.